Rechallenging with immune checkpoint inhibition after a treatment-limiting immune-related adverse event.-MedSci.cn - 梅斯（MedSci）

Rechallenging with immune checkpoint inhibition after a treatment-limiting immune-related adverse event.

O'Neal, RL; Roberts, K; Hao, ZL; Arnold, SM

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

科室
- - 订阅+
  - 更多科室
工具
服务